Sucampo Pharma (SCMP) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Weighted average common shares outstanding - diluted: 43.44M
Today's EPS Names:
OMID, SICP, SCKT, More
Financial Fact:
Weighted average common shares outstanding - diluted: 43.44M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Sucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $44.11 million.
GUIDANCE:
Sucampo Pharma sees FY2016 EPS of $0.97-$1.07, versus the consensus of $1.05. Sucampo Pharma sees FY2016 revenue of $195-205 million, versus the consensus of $202.3 million.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- Royal Caribbean (RCL) Tops Q3 EPS by 19c; offers guidance
- UPS (UPS) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
